Navigation Links
Lentigen to Move Headquarters and Manufacturing to Gaithersburg
Date:2/13/2008

GAITHERSBURG, Md., Feb. 13 /PRNewswire/ -- Lentigen Corporation today announced the company is moving its corporate headquarters and manufacturing facilities from the University of Maryland Baltimore County TechCenter to a new 26,000 square-foot facility in Gaithersburg.

Located along Maryland's I-270 technology corridor, the expanded facility will accommodate Lentigen's future growth needs as a leading developer and manufacturer of lentiviral vectors and proteins for a wide range of therapeutic and research applications. Two self-contained suites will allow simultaneous multi-product manufacture in compliance with FDA-regulated current good manufacturing practices and EMEA regulatory standards.

"We are very pleased to have found a facility that will meet our expansion requirements for both research-grade and clinical-grade operations," said Tim Ravenscroft, Lentigen's chief executive officer. "Located in the heart of Maryland's technology corridor, we will be well situated to attract talented individuals to our growing organization and to meet the increasing needs of our partners and customers."

About Lentigen Corporation

Lentigen Corporation is a privately owned biotechnology company focused on the development of lentiviral vector technology for a wide range of therapeutic, vaccine and research applications in biotechnology and medicine. Lentiviral vectors are the most efficient vehicles for the delivery of genes or gene silencing sequences stably into cells. Lentigen is a highly collaborative company, co-developing lentiviral vector-based products across a broad spectrum of bench to clinical applications. Partnerships include The National Institutes of Health, The University of Pennsylvania, ThermoFisher Scientific and The U.S. Army. For further information, visit http://www.lentigen.com/

Contact:

Gregory Tiberend

'/>"/>

SOURCE Lentigen Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Lentigen Appoints Tim Ravenscroft as Chief Executive Officer
2. VIRxSYS and Lentigen Announce Litigation Settlement
3. Synosia Therapeutics Appoints Chief Financial Officer to New Company Headquarters in Switzerland
4. Emisphere Technologies, Inc. Moves Into New Corporate Headquarters
5. NicOx Opens U.S. Headquarters in New Jersey
6. Clinsys Clinical Research, Inc. Announces Relocation of Corporate Headquarters
7. ConforMIS Moves Headquarters to Expanded Facilities in Burlington, MA
8. MedImmune Celebrates Opening of New Pilot Lab at Gaithersburg Headquarters
9. Baxters Costa Rica Facility Recognized With Shingo Prize for Excellence in Manufacturing
10. Laureate Announces Manufacturing Agreement with ARIUS for Trop-2 Targeting Antibody
11. ARIUS announces manufacturing Agreement with Laureate Pharma For Trop-2 targeting antibody
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...test pilots push planes to explore their limits, r...and Technology (NIST) are probing the newest micro...curacy at the nanoscale. Better nanoscale measurem...ing production in the semiconductor and nanomanufa...logy uses helium ions to generate the signal used ...
(Date:9/5/2008)...e Food & Drug Administration (FDA) issued in July ...port acknowledged that nanoscale materials potenti... by the agency and that those materials present ch...elevant to product safety and effectiveness may ch...icipating the potential for rapid commercializatio...
(Date:9/5/2008)...us, gold is only valuable if we possess it in larg...le isn,t the case for those interested in exploiti...ariety of chemical reactions, including the oxidat...s carbon dioxide at room temperatures. That proces...e effectiveness of catalytic converters that clean...
(Date:9/5/2008)...ept. 5 /- Gen-Probe Incorpo...mpany will present at the Morgan,Stanley Global He...r 9,2008 at approximately 2:45 p.m. Eastern Time....and may be accessed through a link on the investor...n-probe.com . The webcast,will be available for 30...
Breaking Biology Technology:NIST studies how new helium ion microscope measures up 2Nanotechnology and the FDA: size matters 2NIST and partners identify tiny gold clusters as top-notch catalysts 2Gen-Probe to Webcast Presentation at the Morgan Stanley Global Healthcare Unplugged Conference 2
...ote on an article on "The Final Death Knell of Chi... was on the walls of the demise of Searle due to t...final remaining Searle facilities in Chicago. Sinc...in Chicago. , ,Fast forward two years to another a...thousands of jobs, Chicago,s biotech space to trip...
...t gave about $400,000 worth of software to Lad L...k youth and their families. Rob Busch, enterprise ...reception last Friday at the non-profit,s Synergy ... ,Microsoft,s software donation will be used to up...e, including the computers and software programs u...
...c Foundry posted mixed financial numbers for the e...enue while still posting a net loss. , ,Revenues w...previous fiscal year, with unit sales up 74 percen... new product offerings and increased marketing eff...t, however, and the company posted a loss of $4.2 ...
...sin is to attract the presence of major pharmaceut...focus on its own environment, said a panel assembl... Medical-Devices Association. , ,Part of building ...cting large corporations, said WBMA President and ...nior consultant with Cushman and Wakefields Busine...
Other Biology Technology:Searle spirit lives on in Chicago as alumni celebrate at former home 2Searle spirit lives on in Chicago as alumni celebrate at former home 3Searle spirit lives on in Chicago as alumni celebrate at former home 4Searle spirit lives on in Chicago as alumni celebrate at former home 5Panel stresses drawing outside biotech firms to state 2
(Date:9/5/2008)...Newswire/ -- Corporate Safe Specialists (CSS),anno...ompany has hired,Thomas P. Hartmann as Senior Dire...newscom.com/cgi-bin/prnh/20080905/AQF028 ), (Logo...F030LOGO ), Ed McGunn, President and CEO of the C...l help the company achieve its strategic objective...
(Date:9/5/2008)...onal Science Foundation has awarded Iowa State Uni....5 million grant to establish the NSF Engineering ...t Iowa State. , The award is part of the Nationa...g Research Centers (ERC) Program. The third-genera...create university and industry partnerships in res...
(Date:9/5/2008)...animals face the challenge of surviving in a chang...n and Universit Claude Bernard Lyon have shown how...t coast of Scotland responds to two consequences o...e unpredictability of winter storms. Dr. Thomas Ez...es are good and food is plentiful, lambs contribut...
(Date:9/5/2008)...nnovative work on a new type of heart stent sensor...r of mechanical engineering at Virginia Tech, a Na...elopment (CAREER) award of $400,000. , The focu...pecific models and experiments to describe what ha... has a unique type of in situ polymer strain-sensi...
Breaking Biology News(10 mins):Corporate Safe Specialists Launches International Sales Efforts 2Iowa State wins $18.5M grant to create NSF Center for Biorenewable Chemicals 2Iowa State wins $18.5M grant to create NSF Center for Biorenewable Chemicals 3Iowa State wins $18.5M grant to create NSF Center for Biorenewable Chemicals 4Goulbourne earns NSF award to research heart stent sensors 2Goulbourne earns NSF award to research heart stent sensors 3Online Career Site Assists Academia in Its Reach 7327 1Online Career Site Assists Academia in Its Reach 7327 2Novavax Announces Favorable Results from Phase I IIa Pandemic Influenza Vaccine Program 2889 1Novavax Announces Favorable Results from Phase I IIa Pandemic Influenza Vaccine Program 2889 2Novavax Announces Favorable Results from Phase I IIa Pandemic Influenza Vaccine Program 2889 3Novavax Announces Favorable Results from Phase I IIa Pandemic Influenza Vaccine Program 2889 4Novavax Announces Favorable Results from Phase I IIa Pandemic Influenza Vaccine Program 2889 5Novavax Announces Favorable Results from Phase I IIa Pandemic Influenza Vaccine Program 2889 6UltraShape Appoints Assaf Eyal as President 26 CEO 7326 1UltraShape Appoints Assaf Eyal as President 26 CEO 7326 2UltraShape Appoints Assaf Eyal as President 26 CEO 7326 3Memory Pharmaceuticals Closes Final Tranche of Equity Financing with The Stanley Medical Research Institute 7324 1Memory Pharmaceuticals Closes Final Tranche of Equity Financing with The Stanley Medical Research Institute 7324 2Memory Pharmaceuticals Closes Final Tranche of Equity Financing with The Stanley Medical Research Institute 7324 3
... Mice given a relatively new cancer drug can survi...elative of smallpox virus, report scientists suppo...ctious Diseases (NIAID), part of the National Inst...ors, suggest that Gleevec or similar drugs might b...llpox vaccine. The classic smallpox vaccine is mad...
... In this week,s journal Nature, scientists at the ...they have solved one of the "holy grail" puzzles o...ism that insures that the exterior of our bodies i...metrically. , In research with zebra fish, as a mo...s Salk Institute colleagues found that retinoic ac...
... Using a common chemotherapy agent, researchers at...f Pathology and Laboratory Medicine found a way to... cancer, shaking it loose from one location in a c...nother, easier to target area. , The discovery, o...the peer-reviewed journal Molecular Cancer Therape...
... University of Nevada, Reno scientists have ended ...h bark beetles make pheromones: they manufacture t...nts produce and which are often used in perfumes. ... were incapable of making these substances. , "The...romone production," said Gary Blomquist, professor...
Other Biology News:Cancer drug slows poxvirus in mice 2Cancer drug slows poxvirus in mice 3Vitamin A's paradoxical role in influencing symmetry during embryonic development revealed 2Vitamin A's paradoxical role in influencing symmetry during embryonic development revealed 3UCLA cancer researchers shake loose hidden biomarker 2Researchers discover key gene involved in bark beetle pheromone production 2
...Maker, 1. Modular system for large format and medi...b-cast or precast gels (26 x 20 cm) simultaneously...mple-to-use 1.0-mm or 1.5-mm pre-assembled hinged ... and unloading.Built-in ceramic heat exchanger and...
Edited by P.J. Delves (1997) An up-to-date review of antibody-raising technologies, this volume provides researchers with immediate access to the protocols they require every day.
Request Info
MOUSE ANTI HUMAN FACTOR I
Biology Products: